Quick10K

⚲

Cyanotech

Filings

10-K	2021-03-31	Filed 2021-06-22
10-Q	2020-12-31	Filed 2021-02-11
10-Q	2020-09-30	Filed 2020-11-12
10-Q	2020-06-30	Filed 2020-08-11
10-K	2020-03-31	Filed 2020-06-23
10-Q	2019-12-31	Filed 2020-02-11
10-Q	2019-09-30	Filed 2019-11-12
10-Q	2019-06-30	Filed 2019-08-13
10-K	2019-03-31	Filed 2019-07-01
10-Q	2018-12-31	Filed 2019-02-13
10-Q	2018-09-30	Filed 2018-11-13
10-Q	2018-06-30	Filed 2018-08-13
10-K	2018-03-31	Filed 2018-06-15
10-Q	2017-12-31	Filed 2018-02-06
10-Q	2017-09-30	Filed 2017-11-06
10-Q	2017-06-30	Filed 2017-08-10
10-K	2017-03-31	Filed 2017-06-22
10-Q	2016-12-31	Filed 2017-02-07
10-Q	2016-09-30	Filed 2016-11-10
10-Q	2016-06-30	Filed 2016-08-15
10-K	2016-03-31	Filed 2016-06-23
10-Q	2015-12-31	Filed 2016-02-11
10-Q	2015-09-30	Filed 2015-11-12
10-Q	2015-06-30	Filed 2015-08-07
10-K	2015-03-31	Filed 2015-07-15
10-Q	2014-12-31	Filed 2015-02-12
10-Q	2014-09-30	Filed 2014-11-12
10-Q	2014-06-30	Filed 2014-08-14
10-K	2014-03-31	Filed 2014-06-27
10-Q	2013-12-31	Filed 2014-02-06
10-Q	2013-09-30	Filed 2013-11-07
10-Q	2013-06-30	Filed 2013-08-12
10-K	2013-03-31	Filed 2013-06-24
10-Q	2012-12-31	Filed 2013-02-07
10-Q	2012-09-30	Filed 2012-11-09
10-Q	2012-06-30	Filed 2012-08-10
10-K	2012-03-31	Filed 2012-06-21
10-Q	2011-12-31	Filed 2012-02-09
10-Q	2011-09-30	Filed 2011-11-14
10-Q	2011-06-30	Filed 2011-08-11
10-K	2011-03-31	Filed 2011-06-23
10-Q	2010-12-31	Filed 2011-02-11
10-Q	2010-09-30	Filed 2010-11-10
10-Q	2010-06-30	Filed 2010-08-12
10-K	2010-03-31	Filed 2010-06-24
10-Q	2009-12-31	Filed 2010-02-11

Reports

8-K	2020-09-25
8-K	2020-08-27
8-K	2020-05-05
8-K	2019-08-22
8-K	2019-06-03
8-K	2019-04-26
8-K	2019-04-12
8-K	2019-01-03
8-K	2018-11-30
8-K	2018-11-06
8-K	2018-08-31
8-K	2018-08-27
8-K	2018-04-13
8-K	2018-01-24

Cyanotech Financials

CYAN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	3	4	4	5	5	4	4	4	3	3	3	4	3	3	3	2	2	2	2	1	2	2	2	1	1	2	2	1	1	1	2	1	1	1
Accounts Receivable	3	3	3	2	3	4	4	4	4	4	5	3	3	4	4	3	4	4	3	3	2	3	2	2	3	2	3	3	3	2	2	2	2	2
Inventory	3	3	4	4	3	3	3	4	4	4	5	5	5	5	7	6	6	6	7	8	8	7	8	8	8	9	10	9	9	10	10	11	12	11
PP&E			5	6	6	7	8	9	10	11	11	12	12	13	20	15	21	22	29	31	32	32	32	32	32	32	32	33	33	33	33	34	34	34
Assets	14	16	17	19	19	22	23	29	29	29	30	30	30	32	32	31	32	35	35	31	31	31	30	29	29	30	31	30	30	29	30	30	34	32
Accounts Payable	1	1	1	2	1	2	2	2	2	2	2	3	3	4	4	3	3	4	4	4	4	4	4	4	3	3	4	4	4	4	4	5	4	3
Long-Term Debt	1	1	1	1	0	2	2	5	5	6	6	5	5	5	5	5	5	8	8	7	8	7	7	7	7	7	7	7	7	6	6	6	7	7
Liabilities	3	3	3	4	3	6	5	8	9	9	9	9	10	11	10	9	10	13	13	13	14	14	13	13	12	12	12	12	13	13	13	15	18	17
Stockholders' Equity		13	14	15	16	17	17	20	20	21	21	21	21	21	22	21	22	22	22	18	17	17	17	17	17	18	19	18	17	16	16	15	15	15


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	6	6	7	6	7	7	7	7	7	7	7	7	7	9	9	9	8	9	8	8	7	10	8	7	9	8	9	8	7	7	10	6	8	8
Cost of Revenue	4	3	4	4	4	4	4	4	4	4	4	5	4	4	4	6	5	5	4	5	5	6	5	5	5	4	5	6	5	5	6	4	4	5
Gross Profit	2	3	3	2	3	3	3	3	3	3	3	3	3	4	4	3	3	3	3	3	3	4	3	3	4	4	4	2	2	2	4	2	4	3
R&D	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A	2	2	2	2	2	2	2	2	3	2	3	3	4	4	3	3	3	3	3	3	3	4	3	3	3	3	3	3	3	3	3	3	3	2
Tax	0	0	0	0	0	0	0	0	0	0	0	0	-1	0	0	0	0	-0	0	3	0	0	0	0	0	0	0	0	0	0	0	-0	-0	-0
Net Income	0																			-4	-1	0	-0	-0	1	1	1	-1	-1	-1	0	-1	-0	0


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating	1		1	2	0	0	0	1	-0	0	-0	2	-0	1	0	1	-0	0	1	-0	0	1	-0	0	0	1		0	-1	-0		-1
Cash Investing	-0		-1	-1	-1	-3	-0	-4	-1	-0	-1	-0	-1	-1	-1	-1	-1	-2	-1	-0	-0	-0	-0	-0	-0	-0		-0	-0	-0		-0
Cash Financing	-0		0	-0	-0	2	-0	3	-0	0	-0	-0	-0	-0	0	0	0	2	-0	-0	0	-0	-0	-0	-0	-0		-0	1	0		0